Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.3.1.900
Consolidated Statements of Operations - USD ($)
12 Months Ended
Nov. 30, 2015
Nov. 30, 2014
Nov. 30, 2013
Revenues:      
Sales of health and beauty aid products - net $ 24,753,950 $ 30,120,299 $ 28,763,369
Other income 35,605 458,246 63,794
Total Revenues 24,789,555 30,578,545 28,827,163
Costs and Expenses:      
Cost of sales 10,445,369 13,630,226 12,302,356
Selling, general and administrative expenses 11,574,045 11,794,603 18,345,284
Advertising, cooperative and promotional expenses 3,524,074 6,155,051 2,921,199
Research and development 75,208 458,984 741,694
Bad debt (recovery) expense (20,730) (24,721) 55,204
Interest expense - related party 1,735,967 314,213 0
Interest expense 15,157 22,259 2,249
Total Costs and Expenses 27,349,090 32,350,615 34,367,986
Restructuring Cost 2,289,406 2,738,570 0
Total Costs and Expenses 29,638,496 35,089,185 34,367,986
(Loss) before (benefit from) Income Taxes (4,848,941) (4,510,640) (5,540,823)
(Benefit from) Income Taxes (1,592,309) (1,707,212) (2,029,541)
(Loss) from Continuing Operations (3,256,632) (2,803,428) (3,511,282)
Discontinued Operations      
Income (loss) from discontinued operations 18,494 (9,647,472) (4,232,159)
Provision for (benefit from) Income Taxes 6,073 (3,651,431) (1,550,193)
Income (loss) from Discontinued Operations 12,421 (5,996,041) (2,681,966)
Net (loss) $ (3,244,211) $ (8,799,469) $ (6,193,248)
(Loss) per Share: Basic      
Continuing Operations (usd per share) $ (0.46) $ (0.40) $ (0.50)
Discontinued Operations (usd per share) 0.00 (0.86) (0.38)
Total (loss) per share (usd per share) (0.46) (1.26) (0.88)
(Loss) per Share: Diluted      
Continuing Operations (usd per share) (0.46) (0.40) (0.50)
Discontinued Operations (usd per share) 0.00 (0.86) (0.38)
Total (loss) per share (usd per share) $ (0.46) $ (1.26) $ (0.88)
Weighted Average Shares Outstanding:      
Basic (shares) 7,006,684 7,006,684 7,037,694
Diluted (shares) 7,006,684 7,006,684 7,037,694